| Trial ID: | L0973 |
| Source ID: | NCT00808990
|
| Associated Drug: |
BioFemale
|
| Title: |
Probiotics and Non Alcoholic Steatohepatitis (NASH)
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Liver Disease
|
| Interventions: |
Dietary Supplement: BioFemale
|
| Outcome Measures: |
SIBO in NASH patients in both treated groups (probiotics treated versus placebo treated) will be evaluated by lactulose breath test;Lactulose breath testFIBROMAX tests will assess severity of NAFLD in patients' group prior to treatment and post treatment;Fibromax test for the evaluation of NAFLD severity
|
| Sponsor/Collaborators: |
Rabin Medical Center
|
| Gender: |
All
|
| Age: |
18 Yearsnan
|
| Phases: |
Phase 1
|
| Enrollment: |
38
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
|
| Start Date: |
15/12/2008
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
18 April 2016
|
| Locations: |
Israel
|
| URL: |
https://clinicaltrials.gov/show/NCT00808990
|
